Immunophenotypic Analysis of Alopecia Areata Progression in a C3H/HeJ Mouse Model 2258053

D Dregyn Bennett (California State Univ., San Marcos) S Syrita Maria Joe (California State University San Marcos) T Tyler Newell (California State University San Marcos) M Marion Berzansky (California State University San Marcos) J Julie Jameson (California State University San Marcos)

Abstract

Abstract Introduction Alopecia areata is a complex polygenic autoimmune disorder that affects approximately 160 million individuals worldwide, manifesting primarily as non-scarring, patchy hair loss. Current treatments utilizing JAK inhibitors necessitate prolonged use and are often accompanied by adverse side effects, such as increased headaches and a heightened risk of respiratory infections. Expanding therapeutic treatment options relies on a better understanding of the autoinflammatory mechanisms initiating and perpetuating alopecia areata. The C3H/HeJ inbred mouse strain is a well-established model for studying the pathogenesis of alopecia areata and validating experimental treatments. However, detailed knowledge of how the cellular immunophenotype in the skin changes during the stages of alopecia areata progression in C3H/HeJ mice is incomplete. Methods We performed immunofluorescence microscopy and flow cytometry to assess the prevalence of macrophages, dendritic cells, B cells, CD4 T helper cells, CD8 T cells and T cells around the hair follicle and surrounding dermis tissue at various stages of disease progression. Cell populations were quantified globally in the skin and per hair follicle. Results Findings indicate distinct immunophenotypic phases of alopecia areata. We defined these stages as: control with no signs of disease, prelesional disease, active disease, established disease, and regrowth. We have carefully immunoprofiled the skin and hair follicles in each of these stages to create an immune blueprint for mapping alopecia areata in natural disease of C3H/HeJ mice. Conclusion Chronologically ordering hair follicle attack pathogenesis may reveal therapeutic targeting of inflammation pathways causing alopecia areata in humans. Funding Source National Alopecia Areata Foundation, NIH training grant 5T34GM136481,COMPASS training grant EDUC5-13667, Jameson Lab funds Topic Categories Basic Autoimmunity (BA)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (5)

D

Dregyn Bennett

California State Univ., San Marcos

S

Syrita Maria Joe

California State University San Marcos

T

Tyler Newell

California State University San Marcos

M

Marion Berzansky

California State University San Marcos

J

Julie Jameson

California State University San Marcos